The ghrelin/GOAT/GHS-R system and energy metabolism

Reviews in Endocrine and Metabolic Disorders

Volumn 12, Issue 3, 2011, Pages 173-186

  Lim, Chung Thong ^a   Kola, Blerina ^a   Korbonits, Márta ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

AMPK; Appetite; Ghrelin; GOAT. GHS R; Obesity

Indexed keywords

ACYLTRANSFERASE; ADENYLATE KINASE; CANNABINOID; EXENDIN 4; GHRELIN; GHRELIN O ACYLTRANSFERASE; GHRELIN RECEPTOR; UNCLASSIFIED DRUG;

ACYLATION; ANOREXIA NERVOSA; ARCUATE NUCLEUS; ARTICLE; ENERGY METABOLISM; GLUCONEOGENESIS; HORMONE ACTION; HORMONE BINDING; HUMAN; HYPOTHALAMUS; LIPID STORAGE; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRADER WILLI SYNDROME; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STOMACH; STOMACH BYPASS;

ACYLTRANSFERASES; ANIMALS; ENERGY METABOLISM; GHRELIN; HUMANS; HYPOTHALAMUS; OBESITY; RECEPTORS, GHRELIN;

EID: 80054866128     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-011-9169-1     Document Type: Article

References (135)

1. Cummings DE. Ghrelin and the short- and long-term regulation ofappetite and body weight. Physiol Behav. 2006;89(1):71-84. (Pubitemid 44164467)
2. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-60. (Pubitemid 129516334)
3. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409(6817):194-8. (Pubitemid 32144284)
4. Soares JB, Roncon-Albuquerque Jr R, Leite-Moreira A. Ghrelin and ghrelin receptor inhibitors: Agents in the treatment of obesity. Expert Opin Ther Targets. 2008;12(9):1177-89.
5. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K. Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology. 1981;108(1):31-9. (Pubitemid 11212793)
6. Leontiou CA, Franchi G, Korbonits M. Ghrelin in neuroendo-crine organs and tumours. Pituitary. 2007;10(3):213-25.
7. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273 (5277):974-7. (Pubitemid 26275178)
8. Palyha OC, Feighner SD, Tan CP, Mc Kee KK, Hreniuk DL, Gao YD, et al. Ligand activation domain of human orphan growth hormone (GH) secretagogue receptor (GHS-R) conserved from Pufferfish to humans. Mol Endocrinol. 2000;14(1):160-9. (Pubitemid 32260335)
9. Castaneda TR, Tong J, Datta R, Culler M, Tschop MH. Ghrelin in the regulation of body weight and metabolism. Front Neuro-endocrinol. 2010;31(1):44-60.
10. Chartrel N, Alvear-Perez R, Leprince J, Iturrioz X, Reaux-Le Goazigo A, Audinot V, et al. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science. 2007;315(5813):766. authorreply 766.
11. Gourcerol G, Coskun T, Craft LS, Mayer JP, Heiman ML, Wang L, et al. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obes Silver Spring. 2007;15(11):2643-52.
12. Nogueiras R, Pfluger P, Tovar S, Arnold M, Mitchell S, Morris A, et al. Effects of obestatin on energy balance and growth hormone secretion in rodents. Endocrinology. 2007;148(1):21-6. (Pubitemid 46021434)
13. Gnanapavan S, Kola B, Bustin SA, Morris DG, Mc Gee P, Fairclough P, et al. The tissue distribution of the m RNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87(6):2988.
14. Korbonits M, Grossman AB. Ghrelin: Update on a novel hormonal system. Eur J Endocrinol. 2004;151 Suppl 1:S67-70. (Pubitemid 39276350)
15. Higgins SC, Gueorguiev M, Korbonits M. Ghrelin, the periph-eral hunger hormone. Ann Med. 2007;39(2):116-36.
16. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem. 2005;280(26):25196-201. (Pubitemid 40934612)
17. Neary NM, Druce MR, Small CJ, Bloom SR. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut. 2006;55(1):135. (Pubitemid 41820653)
18. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite- stimulatingpeptidehormone. Cell. 2008;132(3):387-96. (Pubitemid 351192001)
19. Gualillo O, Lago F, Dieguez C. Introducing GOAT: A target for obesity and anti-diabetic drugs? Trends Pharmacol Sci. 2008;29 (8):398-401.
20. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA. 2008;105(17):6320-5. (Pubitemid 351758344)
21. Lim CT, Kola B, Igreja SC, Grossman AB, Korbonits M. Expression of ghrelin O-acyltransferase (GOAT), the newly-identified ghrelin acylation enzyme, in various human tissues. Endocr Abstr. 2009;19:P123.
22. Hofmann K. A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem Sci. 2000;25(3):111-2. (Pubitemid 30122419)
23. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, et al. GOAT links dietary lipids with the endocrine control ofenergy balance. Nat Med. 2009;15(7):741-5.
24. Zhao TJ, Liang G, Li RL, Xie X, Sleeman MW, Murphy AJ, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA. 2010;107(16):7467-72.
25. Guan XM, Yu H, Palyha OC, Mc Kee KK, Feighner SD, Sirinathsinghji DJ, et al. Distribution of m RNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res. 1997;48(1):23-9. (Pubitemid 27298124)
26. Schellekens H, Dinan TG, Cryan JF. Lean mean fat reducing "ghrelin" machine: Hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity Neuropharmacology. 2010;58 (1):2-16.
27. Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng CH, et al. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor Cell Signal. 2007;19(5):1011-22. (Pubitemid 46437436)
28. Chan CB, Cheng CH. Identification and functional characteriza-tion of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli. Mol Cell Endocrinol. 2004;214(1-2):81-95. (Pubitemid 38210118)
29. Leite-Moreira AF, Soares JB. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov Today. 2007;12(7-8):276-88. (Pubitemid 46467484)
30. van der Lely AJ, Tschop M, Heiman ML, Ghigo E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev. 2004;25(3):426-57. (Pubitemid 38780667)
31. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin-a hormone with multiple functions. Front Neuroendoc-rinol. 2004;25(1):27-68.
32. Lim CT, Kola B, Korbonits M. AMPK as a mediator of hormonal signalling. J Mol Endocrinol. 2010;44(2):87-97.
33. Kluge M, Riedl S, Uhr M, Schmidt D, Zhang X, Yassouridis A, et al. Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol. 2010;162(6):1059-65.
34. Charoenthongtrakul S, Giuliana D, Longo KA, Govek EK, Nolan A, Gagne S, et al. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J Pharmacol Exp Ther. 2009;329(3):1178-86.
35. Carlini VP, Martini AC, Schioth HB, Ruiz RD, Fiol de Cuneo M, de Barioglio SR. Decreased memory for novel object recognition in chronically food-restricted mice is reversed by acute ghrelin administration. Neuroscience. 2008;153(4):929-34.
36. Kojima M, Hosoda H, Kangawa K. Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab. 2004;18(4):517-30. (Pubitemid 39485216)
37. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908-13.
38. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714-9. (Pubitemid 33641587)
39. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab. 2004;287(2):E297-304. (Pubitemid 38943896)
40. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein m RNA levels and body weight in rats. Diabetes. 2001;50(11):2438-43. (Pubitemid 33642759)
41. Small CJ, Bloom SR. Gut hormones and the control ofappetite. Trends Endocrinol Metab. 2004;15(6):259-63.
42. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86(12):5992.
43. Cummings DE, Shannon MH. Roles for ghrelin in the regulation ofappetite and body weight. Arch Surg. 2003;138(4):389-96. (Pubitemid 36417676)
44. Venkova K, Greenwood-Van Meerveld B. Application of ghrelin to gastrointestinal diseases. Curr Opin Investig Drugs. 2008;9 (10):1103-7.
45. Cowley MA, Smith RG, Diano S, Tschop M, Pronchuk N, Grove KL, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003;37(4):649-61. (Pubitemid 36262986)
46. Mano-Otagiri A, Nemoto T, Sekino A, Yamauchi N, Shuto Y, Sugihara H, et al. Growth hormone-releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rats whose expression of ghrelin receptor is attenuated: Evidence that ghrelin receptor is involved in the up-regulation of GHRH expression in the arc. Endocrinology. 2006;147(9):4093-103. (Pubitemid 44268362)
47. Olszewski PK, Grace MK, Billington CJ, Levine AS. Hypotha-lamic paraventricular injections ofghrelin: Effect on feeding and c-Fos immunoreactivity. Peptides. 2003;24(6):919-23. (Pubitemid 37011440)
48. Kohno D, Gao HZ, Muroya S, Kikuyama S, Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes. 2003;52(4):948-56. (Pubitemid 36384265)
49. Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, et al. UCP2 mediates ghrelin's action on NPY/ Ag RP neurons by lowering free radicals. Nature. 2008;454 (7206):846-51.
50. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004;145(6):2607-12. (Pubitemid 38686204)
51. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, et al. Ghrelin-induced food intake is mediated via the orexin pathway Endocrinology. 2003;144(4):1506-12. (Pubitemid 36428493)
52. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLo S ONE. 2008;3(3):e1797.
53. Kageyama H, Takenoya F, Shiba K, Shioda S. Neuronal circuits involving ghrelin in the hypothalamus-mediated regulation of feeding. Neuropeptides. 2010;44(2):133-8.
54. Hori Y Kageyama H, Guan JL, Kohno D, Yada T, Takenoya F, et al. Synaptic interaction between ghrelin- and ghrelin-containing neurons in the rat hypothalamus. Regul Pept. 2008;145(1-3):122-7. (Pubitemid 350296370)
55. Cowley MA. Hypothalamic melanocortin neurons integrate signals ofenergy state. Eur J Pharmacol. 2003;480(1-3):3-11. (Pubitemid 37410356)
56. Guan JL, Okuda H, Takenoya F, Kintaka Y, Yagi M, Wang L, et al. Synaptic relationships between proopiomelanocortin- and ghrelin-containing neurons in the rat arcuate nucleus. Regul Pept. 2008;145(1-3):128-32. (Pubitemid 350296371)
57. Horvath TL, Diano S, van den Pol AN. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J Neurosci. 1999;19 (3):1072-87. (Pubitemid 29066169)
58. Shrestha YB, Wickwire K, Giraudo SQ. Role of Ag RP on Ghrelin-induced feeding in the hypothalamic paraventricular nucleus. Regul Pept. 2006;133(1-3):68-73. (Pubitemid 41820338)
59. Tschop M, Statnick MA, Suter TM, Heiman ML. GH-releasing peptide-2 increases fat mass in mice lacking NPY: Indication for a crucial mediating role of hypothalamic agouti-related protein. Endocrinology. 2002;143(2):558-68. (Pubitemid 34107210)
60. Qian S, Chen H, Weingarth D, Trumbauer ME, Novi DE, Guan X, et al. Neither agouti-related protein nor neuropeptide Y is critically required for the regulation of energy homeostasis in mice. Mol Cell Biol. 2002;22(14):5027-35. (Pubitemid 34700694)
61. Luquet S, Perez FA, Hnasko TS, Palmiter RD. NPY/Ag RP neurons are essential for feeding in adult mice but can be ablated inneonates. Science. 2005;310(5748):683-5. (Pubitemid 41528162)
62. Gropp E, Shanabrough M, Borok E, Xu AW, Janoschek R, Buch T, et al. Agouti-related peptide-expressing neurons are mandato-ry for feeding. Nat Neurosci. 2005;8(10):1289-91. (Pubitemid 41630413)
63. Ste Marie L, Luquet S, Cole TB, Palmiter RD. Modulation of neuropeptide Y expression in adult mice does not affect feeding. Proc Natl Acad Sci USA. 2005;102(51):18632-7. (Pubitemid 43011277)
64. Bewick GA, Gardiner JV, Dhillo WS, Kent AS, White NE, Webster Z, et al. Post-embryonic ablation of Ag RP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 2005;19 (12):1680-2. (Pubitemid 41429528)
65. Tolle V, Low MJ. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice. Diabetes. 2008;57(1):86-94.
66. Shaw AM, Irani BG, Moore MC, Haskell-Luevano C, Millard WJ. Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice. Peptides. 2005;26(10):1720-7. (Pubitemid 41354529)
67. Minokoshi Y Alquier T, Furukawa N, Kim YB, Lee A, Xue B, et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature. 2004;428(6982):569-74. (Pubitemid 38480541)
68. Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M. Expanding role of AMPK in endocrinology Trends Endocrinol Metab. 2006;17(5):205-15. (Pubitemid 43974977)
69. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005;2(1):9-19. (Pubitemid 43239821)
70. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005;2(1):21-33. (Pubitemid 43239822)
71. Suzuki A, Kusakai G, Kishimoto A, Shimojo Y, Ogura T, Lavin MF, et al. IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner. Biochem Biophys Res Commun. 2004;324(3):986-92. (Pubitemid 39361605)
72. Momcilovic M, Hong SP, Carlson M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem. 2006;281 (35):25336-43. (Pubitemid 44401921)
73. Fu X, Wan S, Lyu YL, Liu LF, Qi H. Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLo S ONE. 2008;3(4):e2009.
74. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J. 2007;403 (1):139-48. (Pubitemid 46569875)
75. Qi J, Gong J, Zhao T, Zhao J, Lam P, Ye J, et al. Downregulation of AMP-activated protein kinase by Cidea-mediated ubiquitina-tion and degradation in brown adipose tissue. EMBO J. 2008;27 (11):1537-48. (Pubitemid 351794037)
76. Costanzo-Garvey DL, Pfluger PT, Dougherty MK, Stock JL, Boehm M, Chaika O, et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab. 2009;10(5):366-78.
77. Kubota N, Yano W, Kubota T, Yamauchi T, Itoh S, Kumagai H, et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 2007;6 (1):55-68. (Pubitemid 47007437)
78. Kola B, Christ-Crain M, Lolli F, Arnaldi G, Giacchetti G, Boscaro M, et al. Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. J Clin Endocrinol Metab. 2008;93 (12):4969-73.
79. Christ-Crain M, Kola B, Lolli F, Fekete C, Seboek D, Wittmann G, et al. AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: A novel mechanism in Cushing's syndrome. FASEB J. 2008;22(6):1672-83. (Pubitemid 351811445)
80. Kola B, Korbonits M. Shedding light on the intricate puzzle of ghrelin's effects on appetite regulation. J Endocrinol. 2009;202 (2):191-8.
81. Lopez M, Lage R, Saha AK, Perez-Tilve D, Vazquez MJ, Varela L, et al. Hypothalamic fatty acid metabolism mediates the orexigenic action ofghrelin. Cell Metab. 2008;7(5):389-99. (Pubitemid 351618114)
82. Kohno D, Sone H, Minokoshi Y, Yada T. Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem Biophys Res Commun. 2008;366(2):388-92. (Pubitemid 50010409)
83. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, et al. Hypothalamic Ca MKK2 contributes to the regulation of energy balance. Cell Metab. 2008;7(5):377-88. (Pubitemid 351598022)
84. Sleeman MW, Latres E. The CAMplexities of central ghrelin. Cell Metab. 2008;7(5):361-2. (Pubitemid 351598032)
85. He W, Lam TK, Obici S, Rossetti L. Molecular disruption of hypothalamic nutrient sensing induces obesity Nat Neurosci. 2006;9(2):227-33. (Pubitemid 43164546)
86. Obici S, Feng Z, Arduini A, Conti R, Rossetti L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med. 2003;9(6):756-61. (Pubitemid 36749226)
87. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, et al. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest. 2006;116(4):1081-91.
88. Sangiao-Alvarellos S, Varela L, Vazquez MJ, Boit KD, Saha AK, Cordido F, Dieguez C, Lopez M. Influence of ghrelin and GH deficiency on AMPK and hypothalamic lipid metabolism. J Neuroendocrinol 2010.
89. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energybalance. Endocr Rev. 2006;27(1):73-100. (Pubitemid 43228239)
90. Kirkham TC, Tucci SA. Endocannabinoids in appetite control and the treatment of obesity. CNS Neurol Disord Drug Targets. 2006;5(3):272-92.
91. Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, et al. Leptin-regulated endocannabinoids are involved in maintain-ing food intake. Nature. 2001;410(6830):822-5. (Pubitemid 32303781)
92. Zbucki RL, Sawicki B, Hryniewicz A, Winnicka MM. Cannabi-noids enhance gastric X/A-like cells activity. Folia Histochem Cytobiol. 2008;46(2):219-24.
93. Rigault C, Le Borgne F, Georges B, Demarquoy J. Ghrelin reduces hepatic mitochondrial fatty acid beta oxidation. J Endocrinol Investig. 2007;30(4):RC4-8.
94. Sangiao-Alvarellos S, Vazquez MJ, Varela L, Nogueiras R, Saha AK, Cordido F, et al. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology. 2009;150(10):4562-74.
95. Rodriguez A, Gomez-Ambrosi J, Catalan V, Gil MJ, Becerril S, Sainz N, et al. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes Lond. 2009;33(5):541-52.
96. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, et al. Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest. 2006;116 (7):1983-93. (Pubitemid 44033322)
97. Baran K, Preston E, Wilks D, Cooney GJ, Kraegen EW, Sainsbury A. Chronic central melanocortin-4 receptor antago-nism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes. 2002;51 (1):152-8. (Pubitemid 34517992)
98. Lage R, Vazquez MJ, Varela L, Saha AK, Vidal-Puig A, Nogueiras R, et al. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J. 2010;24(8):2670-9.
99. Tsubone T, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. Ghrelin regulates adiposity in white adipose tissue and UCP1 m RNA expression in brown adipose tissue in mice. Regul Pept. 2005;130(1-2):97-103. (Pubitemid 40966028)
100. Barazzoni R, Bosutti A, Stebel M, Cattin MR, Roder E, Visintin L, et al. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab. 2005;288(1):E228-35. (Pubitemid 40023812)
101. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006;3(5):379-86.
102. Andrews ZB, Erion DM, Beiler R, Choi CS, Shulman GI, Horvath TL. Uncoupling protein-2 decreases the lipogenic actions ofghrelin. Endocrinology 2010;151(5):2078-86.
103. Mano-Otagiri A, Iwasaki-Sekino A, Nemoto T, Ohata H, Shuto Y, Nakabayashi H, et al. Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats. Regul Pept. 2010;160(1-3):81-90.
104. Krsek M, Rosicka M, Papezova H, Krizova J, Kotrlikova E, Haluz'k M, et al. Plasma ghrelin levels and malnutrition: A comparison of two etiologies. Eat Weight Disord. 2003;8 (3):207-11.
105. Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 2002;8(7):643-4. (Pubitemid 34778697)
106. Bizzarri C, Rigamonti AE, Luce A, Cappa M, Cella SG, Berini J, et al. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur J Endocrinol. 2010;162 (3):499-505.
107. Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, et al. Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab. 2005;90(5):2681-90. (Pubitemid 40686309)
108. Nicholls RD, Knepper JL. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet. 2001;2:153-75. (Pubitemid 35265004)
109. Del Parigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, et al. High circulating ghrelin: A potential cause for hyperphagia and obesity in prader-willi syndrome. J Clin Endocrinol Metab. 2002;87(12):5461-4.
110. Gimenez-Palop O, Gimenez-Perez G, Mauricio D, Gonzalez-Clemente JM, Potau N, Berlanga E, et al. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clin Endocrinol Oxf. 2007;66(2):198-204. (Pubitemid 46096138)
111. Karczewska-Kupczewska M, Straczkowski M, Adamska A, Nikolajuk A, Otziomek E, Gorska M, et al. Increased suppres-sion of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. Eur J Endocrinol. 2010;162 (2):235-9.
112. Liu G, Fortin JP, Beinborn M, Kopin AS. Four missense mutations in the ghrelin receptor result in distinct pharmacolog-ical abnormalities. J Pharmacol Exp Ther. 2007;322(3): 1036-43. (Pubitemid 47295807)
113. Ukkola O, Ravussin E, Jacobson P, Snyder EE, Chagnon M, Sjostrom L, et al. Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab. 2001;86(8):3996-9. (Pubitemid 32756010)
114. Garcia EA, King P, Sidhu K, Ohgusu H, Walley A, Lecoeur C, et al. The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes. Eur J Endocrinol. 2009;161 (2):307-15.
115. Larsen LH, Gjesing AP, Sorensen TI, Hamid YH, Echwald SM, Toubro S, et al. Mutation analysis of the preproghrelin gene: No association with obesity and type 2 diabetes. Clin Biochem. 2005;38(5):420M4.
116. Steinle NI, Pollin TI, O'Connell JR, Mitchell BD, Shuldiner AR. Variants in the ghrelin gene are associated with metabolic syndrome in the Old Order Amish. J Clin Endocrinol Metab. 2005;90(12):6672-7. (Pubitemid 41759331)
117. Bing C, Ambye L, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, et al. Large-scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits. Diabet Med. 2005;22(9):1157-60. (Pubitemid 41224173)
118. Choi HJ, Cho YM, Moon MK, Choi HH, Shin HD, Jang HC, et al. Polymorphisms in the ghrelin gene are associated with serum high-density lipoprotein cholesterol level and not with type 2 diabetes mellitus in Koreans. J Clin Endocrinol Metab. 2006;91 (11):4657-63.
119. Kuzuya M, Ando F, Iguchi A, Shimokata H. Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort. Int J Obes Lond. 2006;30(11):1609-14. (Pubitemid 44657834)
120. Kim SY, Jo DS, Hwang PH, Park JH, Park SK, Yi HK, et al. Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism. 2006;55(3):366-70. (Pubitemid 43234391)
121. Korbonits M, Gueorguiev M, O'Grady E, Lecoeur C, Swan DC, Mein CA, et al. A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab. 2002;87(8):4005-8. (Pubitemid 34879563)
122. Poykko S, Ukkola O, Kauma H, Savolainen MJ, Kesaniemi YA. Ghrelin Arg51Gln mutation is a risk factor for Type 2 diabetes and hypertension in a random sample of middle-aged subjects. Diabetologia. 2003;46(4):455-8. (Pubitemid 36577786)
123. Zavarella S, Petrone A, Zampetti S, Gueorguiev M, Spoletini M, Mein CA, et al. A new variation in the promoter region, the -604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance. Int J Obes Lond. 2008;32(4):663-8. (Pubitemid 351536011)
124. Berthold HK, Giannakidou E, Krone W, Mantzoros CS, Gouni-Berthold I. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes. Clin Chim Acta. 2009;399(1-2):112-6.
125. Garcia EA, Heude B, Petry CJ, Gueorguiev M, Hassan-Smith ZK, Spanou A, et al. Ghrelin receptor gene polymorphisms and body size in children and adults. J Clin Endocrinol Metab. 2008;93(10):4158-61.
126. Gueorguiev M, Lecoeur C, Benzinou M, Mein CA, Meyre D, Vatin V, et al. A genetic study of the ghrelin and growth hormone secretagogue receptor (GHSR) genes and stature. Ann Hum Genet. 2009;73(1):1-9.
127. Gueorguiev M, Lecoeur C, Meyre D, Benzinou M, Mein CA, Hinney A, et al. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity Obes Silver Spring. 2009;17(4):745-54.
128. Fobi MA. Surgical treatment of obesity: A review. J Natl Med Assoc. 2004;96(1):61-75. (Pubitemid 38095686)
129. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346(21):1623-30. (Pubitemid 34755670)
130. Thaler JP, Cummings DE. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009;150(6):2518-25.
131. Williams DL, Grill HJ, Cummings DE, Kaplan JM. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 2003;144(12):5184-7. (Pubitemid 37476045)
132. Zorrilla EP, Iwasaki S, Moss JA, Chang J, Otsuji J, Inoue K, et al. Vaccination against weight gain. Proc Natl Acad Sci USA. 2006;103(35):13226-31. (Pubitemid 44338944)
133. Perez-Tilve D, Gonzalez-Matias L, Alvarez-Crespo M, Leiras R, Tovar S, Dieguez C, et al. Exendin-4 potently decreases ghrelin levels in fasting rats. Diabetes. 2007;56(1):143-51.
134. Ariyasu H, Takaya K, Iwakura H, Hosoda H, Akamizu T, Arai Y, et al. Transgenic mice overexpressing des-acyl ghrelin show small phenotype. Endocrinology 2005;146(1):355-64. (Pubitemid 40051759)
135. Iwakura H, Hosoda K, Son C, Fujikura J, Tomita T, Noguchi M, et al. Analysis of rat insulin II promoter-ghrelin transgenic mice and rat glucagon promoter-ghrelin transgenic mice. J Biol Chem. 2005;280(15):15247-56. (Pubitemid 40562881)